BioSpace News Archive

Vapotherm Inc. today announced the publication of a key prospective, multi-center randomized controlled trial. The study demonstrates the non-inferiority of High Velocity Nasal Insufflation (HVNI) to traditional Non-invasive Positive Pressure Ventilation (NiPPV) in the treatment of adult patients with undifferentiated respiratory distress presenting in the Emergency Department. The study included 204 patients and was conducted at five U.S.

Remarks from FDA Commissioner Scott Gottlieb, M.D.

Having a voice at the Cabinet table key to addressing Canada’s aging population

MedReleaf Corp. is pleased to announce that, at the special meeting of shareholders of MedReleaf held, the shareholders of MedReleaf voted in favour of a special resolution to approve the proposed transaction, pursuant to which, among other things, Aurora Cannabis Inc. will acquire all of the issued and outstanding shares of MedReleaf.

Hill-Rom Holdings, Inc. announced that its board of directors declared a fiscal 2018 fourth quarter dividend of $0.20 per share payable on September 28, 2018, to shareholders of record as of the close of business on September 21, 2018.

Board and Management Continue to Take Action to Improve Internal Practices

Technavio has announced their latest pipeline analysis report on the Wilson’s disease market.

Second-quarter reported sales growth of 17.0 percent; GAAP EPS from continuing operations of $0.40

PainReform Ltd has received FDA approval to conduct two pivotal Phase III clinical trials for post-operative pain relief in soft and hard tissue.

EVIO Inc. announced that it will be exhibiting Booth #1113 at the National Cannabis Industry Association’s 5th Annual Cannabis Business Summit & Expo coming to San Jose, CA July 25-27, 2018.